Printer Friendly

TSI CORPORATION ANNOUNCES MANAGEMENT APPOINTMENTS

 WORCESTER, Mass., Feb. 3 /PRNewswire/ -- TSI Corporation (NASDAQ: TSIN) announced today three management appointments to reconfigure its life sciences and biologics operations. Cary S. Garner, Senior Vice President, will direct the Company's U.S. Life Sciences Group, consisting of its preclinical and clinical premarket testing business. This integration of pharmaceutical testing operations places all pre-approval drug development activities under a single manager. Paul Morrison will head TSI Europe, Ltd., and Lisa Pisano, Senior Vice President, will direct the Company's biologics unit, TSI Biologics.
 The new management alignment follows the departure of Robert Horne, former Senior Vice President of Operations, and Munro Pitt, Senior Vice President and Chief Financial Officer, who have resigned to pursue other interests.
 "The appointments and the integration of our pharmaceutical testing activities will provide our clients with the full range of premarket testing services necessary for product registration and marketing approval," said James P. Sherblom, Chairman and CEO of TSI. "In addition, the streamlined management structure, which essentially eliminates a layer of central management, is expected to reduce our overall cost structure."
 TSI is a life sciences company offering in vitro and in vivo preclinical and toxicology testing services, human clinical testing services, and diagnostic intermediate products. TSI is developing advanced toxicology tests and disease models based on genetic engineering and transgenic techniques to improve the efficiency of the pharmaceutical/clinical development process.
 -0- 2/3/93
 /CONTACT: Patricia F. Dimond, Ph.D., director, corporate communications of TSI Corporation, 508-755-0550; Robert Gottlieb, senior vice president of Feinstein Partners, 617-577-8110, for TSI Corporation/
 (TSIN)


CO: TSI Corporation ST: Massachusetts IN: MTC SU: PER

CH -- NE001 -- 2220 02/03/93 08:12 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1993
Words:275
Previous Article:3M REPORTS HIGHER 4TH-QUARTER, FULL-YEAR EARNINGS
Next Article:SUNBEAM-OSTER REPORTS STRONG FOURTH QUARTER AND FULL YEAR RESULTS
Topics:


Related Articles
TSI ANNOUNCES Q2 OUTLOOK AND MANAGEMENT APPOINTMENTS
TSI ANNOUNCES CONVERTIBILITY OF PREFERRED STOCK
TSI COMPLETES ACQUISITION OF HSRI
TSI CORPORATION ANNOUNCES BOARD CHANGES
TSI CORPORATION ANNOUNCES BOARD CHANGES
TSI CORPORATION ANNOUNCES BOARD CHANGES
TSI CORPORATION TO ACQUIRE CLINICAL RESEARCH GROUP
TSI CORP. ANNOUNCES RESTRUCTURING AND FORECASTS YEAR-END RESULTS
ROBERT HORNE JOINS TSI CORPORATION AS SENIOR VP OF OPERATIONS
TSI CORPORATION REPORTS RECORD FIRST QUARTER REVENUES

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters